Literature DB >> 6798124

Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action.

P J Conlon, C S Henney, S Gillis.   

Abstract

The responsiveness of murine thymocytes to T cell mitogens was examined in the presence of highly purified preparations of IL 1 and IL 2. Fractionation of thymocytes by selective agglutination with peanut lectin (Arachius hypogeae) resulted in separation of two cell populations, each of which mediated distinctive responses to cytokine stimulation. The majority of thymus cells, agglutinated by the lectin (PNA+), were found to be unresponsive to mitogen in the presence of the macrophage-derived factor, IL 1; but showed marked proliferation when stimulated by mitogen in concert with the T cell-derived factor, IL 2. The nonagglutinated fraction, (PNA- cells) demonstrated substantial levels of proliferation after stimulation with mitogen in the absence of any exogenous factors. Moreover, IL 1 alone was highly mitogenic for PNA-thymocytes. This stimulation was further shown to result in the subsequent release of IL 2, as assessed by both the detection of IL 2 by lymphokine-dependent T cell lines and the inhibition of IL 1-dependent mitogenesis by the presence of anti-IL 2 monoclonal antibody. These results further substantiate the important immunoregulatory nature of these proteins and elucidates the possible role of these substances in the ontogeny of T cell responsiveness.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6798124

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Therapy of secondary T-cell immunodeficiencies with biological substances and drugs.

Authors:  J W Hadden; E M Hadden
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  Distinct kinetic responses in vivo of cortical thymocytes of ageing mice to primary as compared to secondary peripheral antigenic stimulation.

Authors:  P Luscieti; P Graff; M Luethi; H Cottier; M W Hess; R Kraft; R D Stoner
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

3.  Studies on the immunological disturbance in murine schistosomiasis japonica from the viewpoint of the interleukin cascade reaction.

Authors:  T Yamashita; T Watanabe; F Sendo
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Cyclic AMP--an intracellular second messenger for interleukin 1.

Authors:  F Shirakawa; U Yamashita; M Chedid; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.

Authors:  Mizuho Nosaka; Yuko Ishida; Aki Tanaka; Takahito Hayashi; Tomoko Miyashita; Chikako Kaminaka; Wolfgang Eisenmenger; Fukumi Furukawa; Akihiko Kimura
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

6.  Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies.

Authors:  E Fishbein; J Alcocer-Varela; D Alarcón-Segovia
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

7.  Idiopathic production of interleukin-1 in acquired immune deficiency syndrome.

Authors:  J L Lepe-Zuniga; P W Mansell; E M Hersh
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

8.  Bleomycin-stimulated hamster alveolar macrophages release interleukin-1.

Authors:  A Suwabe; K Takahashi; S Yasui; S Arai; F Sendo
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

9.  Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na).

Authors:  H Nagai; K Kitagaki; K Kuwabara; A Koda
Journal:  Agents Actions       Date:  1992-11

10.  Enhancing effect of mouse peritoneal exudate cells and their products on antibody productivity of hybridoma cells: application of in vivo factors to in vitro culture.

Authors:  T Mikami; F Makishima; E Suzuki
Journal:  Cytotechnology       Date:  1991-10       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.